APO Research
Talk to an analyst

APO RESEARCH · REPORT

BCG Vaccine

BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.

Selected research

Market Analysis & Forecast

Global BCG Vaccine Market Analysis and Forecast 2026-2032

1 January 2026195 pages

Choose your research edition.

Industry ResearchBCG Vaccine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal BCG Vaccine Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal BCG Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal BCG Vaccine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal BCG Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.

Japan is the largest BCG Vaccine market with about 30% market share. North America is follower, accounting for about 29% market share.The key manufacturers are Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax, GSBPL etc. Top 3 companies occupied about 77% market share.

This report presents an overview of global market for BCG Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of BCG Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for BCG Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the BCG Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global BCG Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for BCG Vaccine sales, projected growth trends, production technology, application and end-user industry.

BCG Vaccine Segment by Company

Merck

Sanofi Pasteur

Japan BCG Lab

China National Biotec

Serum Institute of India

Intervax

GSBPL

BCG Vaccine Segment by Type

Immune BCG

Therapy BCG

BCG Vaccine Segment by Application

Hospitals

Clinics

Others

BCG Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global BCG Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of BCG Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of BCG Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of BCG Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of BCG Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, BCG Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global BCG Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Immune BCG Major Manufacturers Table 3. Therapy BCG Major Manufacturers Table 4. Global BCG Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Major Manufacturers Table 6. Clinics Major Manufacturers Table 7. Others Major Manufacturers Table 8. BCG Vaccine Industry Trends Table 9. BCG Vaccine Industry Drivers Table 10. BCG Vaccine Industry Opportunities and Challenges Table 11. BCG Vaccine Industry Restraints Table 12. Global BCG Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global BCG Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 14. Global BCG Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 15. Global BCG Vaccine Revenue Market Share by Region (2021-2026) Table 16. Global BCG Vaccine Revenue Market Share by Region (2027-2032) Table 17. Global BCG Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (MT) Table 18. Global BCG Vaccine Sales by Region (2021-2026) & (MT) Table 19. Global BCG Vaccine Sales by Region (2027-2032) & (MT) Table 20. Global BCG Vaccine Sales Market Share by Region (2021-2026) Table 21. Global BCG Vaccine Sales Market Share by Region (2027-2032) Table 22. Global BCG Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global BCG Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 24. Global BCG Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global BCG Vaccine Sales Market Share by Manufacturers (2021-2026) Table 26. Global BCG Vaccine Sales Price (USD/Kg) of Manufacturers (2021-2026) Table 27. Global BCG Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global BCG Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global BCG Vaccine Manufacturers, Product Type & Application Table 30. Global BCG Vaccine Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global BCG Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global BCG Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global BCG Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 35. Global BCG Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 36. Global BCG Vaccine Revenue Market Share by Type (2021-2026) Table 37. Global BCG Vaccine Revenue Market Share by Type (2027-2032) Table 38. Global BCG Vaccine Sales by Type 2021 VS 2025 VS 2032 (MT) Table 39. Global BCG Vaccine Sales by Type (2021-2026) & (MT) Table 40. Global BCG Vaccine Sales by Type (2027-2032) & (MT) Table 41. Global BCG Vaccine Sales Market Share by Type (2021-2026) Table 42. Global BCG Vaccine Sales Market Share by Type (2027-2032) Table 43. Global BCG Vaccine Price by Type (2021-2026) & (USD/Kg) Table 44. Global BCG Vaccine Price by Type (2027-2032) & (USD/Kg) Table 45. Global BCG Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global BCG Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 47. Global BCG Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 48. Global BCG Vaccine Revenue Market Share by Application (2021-2026) Table 49. Global BCG Vaccine Revenue Market Share by Application (2027-2032) Table 50. Global BCG Vaccine Sales by Application 2021 VS 2025 VS 2032 (MT) Table 51. Global BCG Vaccine Sales by Application (2021-2026) & (MT) Table 52. Global BCG Vaccine Sales by Application (2027-2032) & (MT) Table 53. Global BCG Vaccine Sales Market Share by Application (2021-2026) Table 54. Global BCG Vaccine Sales Market Share by Application (2027-2032) Table 55. Global BCG Vaccine Price by Application (2021-2026) & (USD/Kg) Table 56. Global BCG Vaccine Price by Application (2027-2032) & (USD/Kg) Table 57. Merck Company Information Table 58. Merck Business Overview Table 59. Merck BCG Vaccine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 60. Merck BCG Vaccine Product Portfolio Table 61. Merck Recent Development Table 62. Sanofi Pasteur Company Information Table 63. Sanofi Pasteur Business Overview Table 64. Sanofi Pasteur BCG Vaccine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 65. Sanofi Pasteur BCG Vaccine Product Portfolio Table 66. Sanofi Pasteur Recent Development Table 67. Japan BCG Lab Company Information Table 68. Japan BCG Lab Business Overview Table 69. Japan BCG Lab BCG Vaccine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 70. Japan BCG Lab BCG Vaccine Product Portfolio Table 71. Japan BCG Lab Recent Development Table 72. China National Biotec Company Information Table 73. China National Biotec Business Overview Table 74. China National Biotec BCG Vaccine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 75. China National Biotec BCG Vaccine Product Portfolio Table 76. China National Biotec Recent Development Table 77. Serum Institute of India Company Information Table 78. Serum Institute of India Business Overview Table 79. Serum Institute of India BCG Vaccine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 80. Serum Institute of India BCG Vaccine Product Portfolio Table 81. Serum Institute of India Recent Development Table 82. Intervax Company Information Table 83. Intervax Business Overview Table 84. Intervax BCG Vaccine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 85. Intervax BCG Vaccine Product Portfolio Table 86. Intervax Recent Development Table 87. GSBPL Company Information Table 88. GSBPL Business Overview Table 89. GSBPL BCG Vaccine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 90. GSBPL BCG Vaccine Product Portfolio Table 91. GSBPL Recent Development Table 92. North America BCG Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 93. North America BCG Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 94. North America BCG Vaccine Sales by Type (2021-2026) & (MT) Table 95. North America BCG Vaccine Sales by Type (2027-2032) & (MT) Table 96. North America BCG Vaccine Sales Price by Type (2021-2026) & (USD/Kg) Table 97. North America BCG Vaccine Sales Price by Type (2027-2032) & (USD/Kg) Table 98. North America BCG Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 99. North America BCG Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 100. North America BCG Vaccine Sales by Application (2021-2026) & (MT) Table 101. North America BCG Vaccine Sales by Application (2027-2032) & (MT) Table 102. North America BCG Vaccine Sales Price by Application (2021-2026) & (USD/Kg) Table 103. North America BCG Vaccine Sales Price by Application (2027-2032) & (USD/Kg) Table 104. North America BCG Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America BCG Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 106. North America BCG Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 107. North America BCG Vaccine Sales by Country (2021 VS 2025 VS 2032) & (MT) Table 108. North America BCG Vaccine Sales by Country (2021-2026) & (MT) Table 109. North America BCG Vaccine Sales by Country (2027-2032) & (MT) Table 110. North America BCG Vaccine Sales Price by Country (2021-2026) & (USD/Kg) Table 111. North America BCG Vaccine Sales Price by Country (2027-2032) & (USD/Kg) Table 112. United States BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 113. Canada BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 114. Mexico BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 115. Europe BCG Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 116. Europe BCG Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 117. Europe BCG Vaccine Sales by Type (2021-2026) & (MT) Table 118. Europe BCG Vaccine Sales by Type (2027-2032) & (MT) Table 119. Europe BCG Vaccine Sales Price by Type (2021-2026) & (USD/Kg) Table 120. Europe BCG Vaccine Sales Price by Type (2027-2032) & (USD/Kg) Table 121. Europe BCG Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 122. Europe BCG Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 123. Europe BCG Vaccine Sales by Application (2021-2026) & (MT) Table 124. Europe BCG Vaccine Sales by Application (2027-2032) & (MT) Table 125. Europe BCG Vaccine Sales Price by Application (2021-2026) & (USD/Kg) Table 126. Europe BCG Vaccine Sales Price by Application (2027-2032) & (USD/Kg) Table 127. Europe BCG Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Europe BCG Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 129. Europe BCG Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 130. Europe BCG Vaccine Sales by Country (2021 VS 2025 VS 2032) & (MT) Table 131. Europe BCG Vaccine Sales by Country (2021-2026) & (MT) Table 132. Europe BCG Vaccine Sales by Country (2027-2032) & (MT) Table 133. Europe BCG Vaccine Sales Price by Country (2021-2026) & (USD/Kg) Table 134. Europe BCG Vaccine Sales Price by Country (2027-2032) & (USD/Kg) Table 135. Germany BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 136. France BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 137. U.K. BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 138. Italy BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 139. Russia BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 140. Spain BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 141. Netherlands BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 142. Switzerland BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 143. Sweden BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 144. Poland BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 145. China BCG Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 146. China BCG Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 147. China BCG Vaccine Sales by Type (2021-2026) & (MT) Table 148. China BCG Vaccine Sales by Type (2027-2032) & (MT) Table 149. China BCG Vaccine Sales Price by Type (2021-2026) & (USD/Kg) Table 150. China BCG Vaccine Sales Price by Type (2027-2032) & (USD/Kg) Table 151. China BCG Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 152. China BCG Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 153. China BCG Vaccine Sales by Application (2021-2026) & (MT) Table 154. China BCG Vaccine Sales by Application (2027-2032) & (MT) Table 155. China BCG Vaccine Sales Price by Application (2021-2026) & (USD/Kg) Table 156. China BCG Vaccine Sales Price by Application (2027-2032) & (USD/Kg) Table 157. Asia BCG Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 158. Asia BCG Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 159. Asia BCG Vaccine Sales by Type (2021-2026) & (MT) Table 160. Asia BCG Vaccine Sales by Type (2027-2032) & (MT) Table 161. Asia BCG Vaccine Sales Price by Type (2021-2026) & (USD/Kg) Table 162. Asia BCG Vaccine Sales Price by Type (2027-2032) & (USD/Kg) Table 163. Asia BCG Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 164. Asia BCG Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 165. Asia BCG Vaccine Sales by Application (2021-2026) & (MT) Table 166. Asia BCG Vaccine Sales by Application (2027-2032) & (MT) Table 167. Asia BCG Vaccine Sales Price by Application (2021-2026) & (USD/Kg) Table 168. Asia BCG Vaccine Sales Price by Application (2027-2032) & (USD/Kg) Table 169. Asia BCG Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Asia BCG Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. Asia BCG Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. Asia BCG Vaccine Sales by Country (2021 VS 2025 VS 2032) & (MT) Table 173. Asia BCG Vaccine Sales by Country (2021-2026) & (MT) Table 174. Asia BCG Vaccine Sales by Country (2027-2032) & (MT) Table 175. Asia BCG Vaccine Sales Price by Country (2021-2026) & (USD/Kg) Table 176. Asia BCG Vaccine Sales Price by Country (2027-2032) & (USD/Kg) Table 177. Japan BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 178. South Korea BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 179. India BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 180. Australia BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 181. Taiwan BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 182. Southeast Asia BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 183. SAMEA BCG Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 184. SAMEA BCG Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 185. SAMEA BCG Vaccine Sales by Type (2021-2026) & (MT) Table 186. SAMEA BCG Vaccine Sales by Type (2027-2032) & (MT) Table 187. SAMEA BCG Vaccine Sales Price by Type (2021-2026) & (USD/Kg) Table 188. SAMEA BCG Vaccine Sales Price by Type (2027-2032) & (USD/Kg) Table 189. SAMEA BCG Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 190. SAMEA BCG Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 191. SAMEA BCG Vaccine Sales by Application (2021-2026) & (MT) Table 192. SAMEA BCG Vaccine Sales by Application (2027-2032) & (MT) Table 193. SAMEA BCG Vaccine Sales Price by Application (2021-2026) & (USD/Kg) Table 194. SAMEA BCG Vaccine Sales Price by Application (2027-2032) & (USD/Kg) Table 195. SAMEA BCG Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. SAMEA BCG Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. SAMEA BCG Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. SAMEA BCG Vaccine Sales by Country (2021 VS 2025 VS 2032) & (MT) Table 199. SAMEA BCG Vaccine Sales by Country (2021-2026) & (MT) Table 200. SAMEA BCG Vaccine Sales by Country (2027-2032) & (MT) Table 201. SAMEA BCG Vaccine Sales Price by Country (2021-2026) & (USD/Kg) Table 202. SAMEA BCG Vaccine Sales Price by Country (2027-2032) & (USD/Kg) Table 203. Brazil BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 204. Argentina BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 205. Chile BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 206. Colombia BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 207. Peru BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 208. Saudi Arabia BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 209. Israel BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 210. UAE BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 211. Turkey BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 212. Iran BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 213. Egypt BCG Vaccine Revenue (2021-2032) & (US$ Million) Table 214. Key Raw Materials Table 215. Raw Materials Key Suppliers Table 216. BCG Vaccine Distributors List Table 217. BCG Vaccine Customers List Table 218. Research Programs/Design for This Report Table 219. Authors List of This Report Table 220. Secondary Sources Table 221. Primary Sources List of Figures Figure 1. BCG Vaccine Image Figure 2. Global BCG Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global BCG Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Immune BCG Image Figure 5. Therapy BCG Image Figure 6. Global BCG Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global BCG Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals Image Figure 9. Clinics Image Figure 10. Others Image Figure 11. Global BCG Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global BCG Vaccine Revenue (2021-2032) & (US$ Million) Figure 13. Global BCG Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global BCG Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global BCG Vaccine Revenue Market Share by Region (2021-2032) Figure 16. Global BCG Vaccine Sales (2021-2032) & (MT) Figure 17. Global BCG Vaccine Sales by Region: 2021 VS 2025 VS 2032 (MT) Figure 18. Global BCG Vaccine Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico BCG Vaccine Sales YoY (2021-2032) & (MT) Figure 20. Europe BCG Vaccine Sales YoY (2021-2032) & (MT) Figure 21. China BCG Vaccine Sales YoY (2021-2032) & (MT) Figure 22. Asia (Excluding China) BCG Vaccine Sales YoY (2021-2032) & (MT) Figure 23. South America, Middle East and Africa BCG Vaccine Sales YoY (2021-2032) & (MT) Figure 24. Global BCG Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global BCG Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global BCG Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global BCG Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global BCG Vaccine Revenue Market Share by Type (2021-2032) Figure 30. Global BCG Vaccine Sales by Type (2021 VS 2025 VS 2032) & (MT) Figure 31. Global BCG Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global BCG Vaccine Sales Market Share by Type (2021-2032) Figure 33. Global BCG Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global BCG Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global BCG Vaccine Revenue Market Share by Application (2021-2032) Figure 36. Global BCG Vaccine Sales by Application (2021 VS 2025 VS 2032) & (MT) Figure 37. Global BCG Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global BCG Vaccine Sales Market Share by Application (2021-2032) Figure 39. North America BCG Vaccine Revenue Share by Type (2021-2032) Figure 40. North America BCG Vaccine Sales Share by Type (2021-2032) Figure 41. North America BCG Vaccine Revenue Share by Application (2021-2032) Figure 42. North America BCG Vaccine Sales Share by Application (2021-2032) Figure 43. North America BCG Vaccine Revenue Share by Country (2021-2032) Figure 44. North America BCG Vaccine Sales Share by Country (2021-2032) Figure 45. Europe BCG Vaccine Revenue Share by Type (2021-2032) Figure 46. Europe BCG Vaccine Sales Share by Type (2021-2032) Figure 47. Europe BCG Vaccine Revenue Share by Application (2021-2032) Figure 48. Europe BCG Vaccine Sales Share by Application (2021-2032) Figure 49. Europe BCG Vaccine Revenue Share by Country (2021-2032) Figure 50. Europe BCG Vaccine Sales Share by Country (2021-2032) Figure 51. China BCG Vaccine Revenue Share by Type (2021-2032) Figure 52. China BCG Vaccine Sales Share by Type (2021-2032) Figure 53. China BCG Vaccine Revenue Share by Application (2021-2032) Figure 54. China BCG Vaccine Sales Share by Application (2021-2032) Figure 55. Asia BCG Vaccine Revenue Share by Type (2021-2032) Figure 56. Asia BCG Vaccine Sales Share by Type (2021-2032) Figure 57. Asia BCG Vaccine Revenue Share by Application (2021-2032) Figure 58. Asia BCG Vaccine Sales Share by Application (2021-2032) Figure 59. Asia BCG Vaccine Revenue Share by Country (2021-2032) Figure 60. Asia BCG Vaccine Sales Share by Country (2021-2032) Figure 61. SAMEA BCG Vaccine Revenue Share by Type (2021-2032) Figure 62. SAMEA BCG Vaccine Sales Share by Type (2021-2032) Figure 63. SAMEA BCG Vaccine Revenue Share by Application (2021-2032) Figure 64. SAMEA BCG Vaccine Sales Share by Application (2021-2032) Figure 65. SAMEA BCG Vaccine Revenue Share by Country (2021-2032) Figure 66. SAMEA BCG Vaccine Sales Share by Country (2021-2032) Figure 67. BCG Vaccine Value Chain Figure 68. Manufacturing Cost Structure Figure 69. BCG Vaccine Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Immune BCG
  • Therapy BCG
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Merck
  • Sanofi Pasteur
  • Japan BCG Lab
  • China National Biotec
  • Serum Institute of India
  • Intervax
  • GSBPL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 BCG Vaccine Market by Type
  3. 1.2.1 Global BCG Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Immune BCG
  5. 1.2.3 Therapy BCG
  6. 1.3 BCG Vaccine Market by Application
  7. 1.3.1 Global BCG Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 Clinics
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 BCG Vaccine Market Dynamics
  1. 2.1 BCG Vaccine Industry Trends
  2. 2.2 BCG Vaccine Industry Drivers
  3. 2.3 BCG Vaccine Industry Opportunities and Challenges
  4. 2.4 BCG Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global BCG Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global BCG Vaccine Revenue by Region
  3. 3.2.1 Global BCG Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global BCG Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global BCG Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global BCG Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global BCG Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global BCG Vaccine Sales by Region
  9. 3.4.1 Global BCG Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global BCG Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global BCG Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global BCG Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global BCG Vaccine Revenue by Manufacturers
  2. 4.1.1 Global BCG Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global BCG Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global BCG Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global BCG Vaccine Sales by Manufacturers
  6. 4.2.1 Global BCG Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global BCG Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global BCG Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global BCG Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global BCG Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global BCG Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global BCG Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global BCG Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global BCG Vaccine Market CR5 and HHI
  16. 4.8.2 2025 BCG Vaccine Tier 1, Tier 2, and Tier 3
5 BCG Vaccine Market by Type
  1. 5.1 Global BCG Vaccine Revenue by Type
  2. 5.1.1 Global BCG Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global BCG Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global BCG Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global BCG Vaccine Sales by Type
  6. 5.2.1 Global BCG Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global BCG Vaccine Sales by Type (2021-2032) & (MT)
  8. 5.2.3 Global BCG Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global BCG Vaccine Price by Type
6 BCG Vaccine Market by Application
  1. 6.1 Global BCG Vaccine Revenue by Application
  2. 6.1.1 Global BCG Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global BCG Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global BCG Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global BCG Vaccine Sales by Application
  6. 6.2.1 Global BCG Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global BCG Vaccine Sales by Application (2021-2032) & (MT)
  8. 6.2.3 Global BCG Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global BCG Vaccine Price by Application
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck BCG Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merck BCG Vaccine Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 Sanofi Pasteur
  8. 7.2.1 Sanofi Pasteur Company Information
  9. 7.2.2 Sanofi Pasteur Business Overview
  10. 7.2.3 Sanofi Pasteur BCG Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Pasteur BCG Vaccine Product Portfolio
  12. 7.2.5 Sanofi Pasteur Recent Developments
  13. 7.3 Japan BCG Lab
  14. 7.3.1 Japan BCG Lab Company Information
  15. 7.3.2 Japan BCG Lab Business Overview
  16. 7.3.3 Japan BCG Lab BCG Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Japan BCG Lab BCG Vaccine Product Portfolio
  18. 7.3.5 Japan BCG Lab Recent Developments
  19. 7.4 China National Biotec
  20. 7.4.1 China National Biotec Company Information
  21. 7.4.2 China National Biotec Business Overview
  22. 7.4.3 China National Biotec BCG Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 China National Biotec BCG Vaccine Product Portfolio
  24. 7.4.5 China National Biotec Recent Developments
  25. 7.5 Serum Institute of India
  26. 7.5.1 Serum Institute of India Company Information
  27. 7.5.2 Serum Institute of India Business Overview
  28. 7.5.3 Serum Institute of India BCG Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Serum Institute of India BCG Vaccine Product Portfolio
  30. 7.5.5 Serum Institute of India Recent Developments
  31. 7.6 Intervax
  32. 7.6.1 Intervax Company Information
  33. 7.6.2 Intervax Business Overview
  34. 7.6.3 Intervax BCG Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Intervax BCG Vaccine Product Portfolio
  36. 7.6.5 Intervax Recent Developments
  37. 7.7 GSBPL
  38. 7.7.1 GSBPL Company Information
  39. 7.7.2 GSBPL Business Overview
  40. 7.7.3 GSBPL BCG Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 GSBPL BCG Vaccine Product Portfolio
  42. 7.7.5 GSBPL Recent Developments
8 North America
  1. 8.1 North America BCG Vaccine Market Size by Type
  2. 8.1.1 North America BCG Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America BCG Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America BCG Vaccine Price by Type (2021-2032)
  5. 8.2 North America BCG Vaccine Market Size by Application
  6. 8.2.1 North America BCG Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America BCG Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America BCG Vaccine Price by Application (2021-2032)
  9. 8.3 North America BCG Vaccine Market Size by Country
  10. 8.3.1 North America BCG Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America BCG Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America BCG Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe BCG Vaccine Market Size by Type
  2. 9.1.1 Europe BCG Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe BCG Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe BCG Vaccine Price by Type (2021-2032)
  5. 9.2 Europe BCG Vaccine Market Size by Application
  6. 9.2.1 Europe BCG Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe BCG Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe BCG Vaccine Price by Application (2021-2032)
  9. 9.3 Europe BCG Vaccine Market Size by Country
  10. 9.3.1 Europe BCG Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe BCG Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe BCG Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China BCG Vaccine Market Size by Type
  2. 10.1.1 China BCG Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China BCG Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China BCG Vaccine Price by Type (2021-2032)
  5. 10.2 China BCG Vaccine Market Size by Application
  6. 10.2.1 China BCG Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China BCG Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China BCG Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia BCG Vaccine Market Size by Type
  2. 11.1.1 Asia BCG Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia BCG Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia BCG Vaccine Price by Type (2021-2032)
  5. 11.2 Asia BCG Vaccine Market Size by Application
  6. 11.2.1 Asia BCG Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia BCG Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia BCG Vaccine Price by Application (2021-2032)
  9. 11.3 Asia BCG Vaccine Market Size by Country
  10. 11.3.1 Asia BCG Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia BCG Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia BCG Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA BCG Vaccine Market Size by Type
  2. 12.1.1 SAMEA BCG Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA BCG Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA BCG Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA BCG Vaccine Market Size by Application
  6. 12.2.1 SAMEA BCG Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA BCG Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA BCG Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA BCG Vaccine Market Size by Country
  10. 12.3.1 SAMEA BCG Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA BCG Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA BCG Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 BCG Vaccine Value Chain Analysis
  2. 13.1.1 BCG Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 BCG Vaccine Production Mode & Process
  6. 13.2 BCG Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 BCG Vaccine Distributors
  9. 13.2.3 BCG Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst